Sickle cell disease trials recruiting in California

All Sickle cell disease trials nationally

Cities in California

Recruiting trials in California

• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · California: Los Angeles, Oakland, Orange
• A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
  NCT06481306 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla, Oakland
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · California: Los Angeles, Madera, Orange, Palo Alto
• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
  NCT06439082 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female) · California: Orange
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
  NCT04398628 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: Los Angeles, Oakland, Sacramento, San Bernardino
• Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
  NCT05685368 · Phase: Phase 1, Phase 2 · Ages: 14 Years to 21 Years · Sex: All (male and female) · California: Los Angeles
• Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
  NCT06071377 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Loma Linda
• Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
  NCT06016634 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: Sacramento
• Exercise in Child Health
  NCT05359991 · Phase: Not applicable (e.g. observational or device study) · Ages: 10 Years to 17 Years · Sex: All (male and female) · California: Irvine
• FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
  NCT06539169 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: Los Altos
• Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
  NCT04819841 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 50 Years · Sex: All (male and female) · California: Los Angeles, Palo Alto
• Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
  NCT03279094 · Phase: Phase 1 · Ages: 1 Year to 30 Years · Sex: All (male and female) · California: Duarte
• Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
  NCT02675959 · Phase: Phase 2 · Ages: 6 Months to 21 Years · Sex: All (male and female) · California: Los Angeles
• Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
  NCT06374238 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 30 Years · Sex: All (male and female) · California: Los Angeles
• Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
  NCT06385886 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Oakland
• Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
  NCT07224360 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Orange
• Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
  NCT06699849 · Phase: Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · California: Oakland, Orange
• Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
  NCT07369024 · Phase: Phase 2 · Ages: 5 Years to 20 Years · Sex: All (male and female) · California: Torrance
• The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
  NCT06975865 · Phase: Phase 3 · Ages: 10 Years to 65 Years · Sex: All (male and female) · California: Fresno
• Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
  NCT04774536 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 35 Years · Sex: All (male and female) · California: Los Angeles, Oakland
• Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
  NCT06260891 · Phase: Phase 2 · Ages: 15 Years to 40 Years · Sex: All (male and female) · California: Oakland